stars 1 stars 2 stars 3

The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality. Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading valued solution provider in reproductive health and to support customers with successful treatment outcomes.

Website http://www.igenomix.eu/
Revenue $21.3 million
Employees 314 (228 on RocketReach)
Founded 1996
Phone +1 305-466-0671
Fax (786) 401-7546
Technologies
Industry Biotechnology Research, Business Services General, Biotechnology, Preimplantation Genetic Diagnosis (PGD), Business Services, Science and Engineering, Preimplantation Genetic Screening (PGS), Genetics, Endometrial Receptivity Array (ERA), Health Care, Products of Conception (POC), Carrier Genetic Test (CGT), Sperm Aneuploidy Test (SAT), Non-invasive Prenatal Test (NACE)
Web Rank 2 Million
Keywords Genetic Testing, Preimplantation Genetic Testing, Medical Genetics, Reproductive Health, Prenatal Diagnostics, Infertility Treatment, Next Generation Sequencing, In Vitro Fertilization, Genetic Screening, Non Invasive Prenatal Testing, Embryo Testing, Genetic Disorders, Molecular Diagnostics, Ivf, Carrier Screening, Chromosome Analysis, Ngs, Nipt, Dna Testing
Competitors Natera, GRAIL, Ancestry, Myriad Genetics, Foundation Medicine, GeneDx, Invitae, Ambry Genetics, Color, 23andMe Inc +25 more (view full list)
SIC SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies

Igenomix Questions

The Igenomix annual revenue was $21.3 million in 2026.

Rupali Chopra is the Laboratory Director of Igenomix.

228 people are employed at Igenomix.

The NAICS codes for Igenomix are [54, 54171, 5417, 541, 541711].

The SIC codes for Igenomix are [80, 283, 28].

Top Igenomix Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users